Our leaders

Rachel Roller is the President and Chief Executive Officer of the Dohmen Company Foundation (DCF). Rachel leads efforts to optimize the Foundation’s vision of life without diet-related disease. Her nearly three decades of leadership experience has focused on improving the health and wellbeing of communities. Prior to joining the Foundation, she founded a successful consulting practice dedicated to addressing health disparities. Rachel’s career also includes serving as Senior Vice President of Government and Community Relations for one of the nation’s largest not-for-profit integrated health care systems for more than a decade. Rachel has also served as a public servant in several leadership capacities. She maintains broad and deep relationships with community leaders and elected officials at all levels of government, understands the power of partnership and has considerable experience building alliances and influential coalitions. A seasoned healthcare strategist, she has developed and implemented comprehensive strategies that have resulted in successful public/private partnerships, clinical and operational transformation, greater healthcare access, and community collaboration such as a signature multi-million-dollar community benefit program. Rachel brings an inclusive and collaborative mindset to DCF’s grant making, investment and public awareness strategies. She maintains an unwavering personal and professional commitment to addressing our nation’s greatest public health threat, the proliferation of diet-related disease.

As the Chief Financial and Chief Investment Officer, Michael leads the Dohmen Company Foundation’s Impact Investment Fund seeking both a ROI but also a SROI (Social Return on Investment) by way of minority equity investments in important early-stage companies that will help Dohmen realize its vision of Life Without Diet Related Disease. He is also responsible for the day-to-day financial operations of Dohmen. Michael joined Dohmen in 2009 after a prestigious career as a financial and corporate development executive for multiple Fortune 500 and life science companies including Deloitte, Cooper Industries, Kimberly Clark, and Schwarz Pharma (now UCB). Michael originally served as the Corporate Development Officer and then also as the CFO for The F. Dohmen Co, providing inorganic growth through strategic acquisitions, culminating with the successful integration, double-digit growth, and ultimate divestiture of what became Dohmen Life Sciences Services (now Eversana). Michael is a graduate of the University of Wisconsin-Whitewater (Magna Cum Laude) and earned his MBA from the University of North Carolina at Chapel Hill. Michael is a lover of nature and enjoys silent sports, the outdoors, and spending free time with his wife and their many pets.